Targeting the undruggable oncogenic KRAS: the dawn of hope.
Asimgil H, Ertetik U, Çevik NC, Ekizce M, Doğruöz A, Gökalp M, Arık-Sever E, Istvanffy R, Friess H, Ceyhan GO, Demir IE.
Asimgil H, et al. Among authors: gokalp m.
JCI Insight. 2022 Jan 11;7(1):e153688. doi: 10.1172/jci.insight.153688.
JCI Insight. 2022.
PMID: 35014625
Free PMC article.
Review.